| VYCRINSA Neurocrine Biosciences, Inc. 2259907 23 Feb 2022 | Protected: Registered/protected | Pharmaceutical preparations for human use; pharmaceutical preparations... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations for human use; pharmaceutical preparations for the diagnosis, prevention and treatment of psychiatric, neurological, hormonal, genetic and endocrine disorders and conditions; pharmaceutical preparations for human use for diagnosis, prevention and treatment of diseases and disorders by gene therapy; pharmaceuticals for human use for the treatment of rare and orphan diseases, disorders and conditions; pharmaceutical preparations for the treatment of congenital adrenal hyperplasia. | |
| VYDESSA Eli Lilly and Company a Indiana corporation 1099417 16 Feb 2006 | Removed - Not renewed: Renewal fee not paid | Pharmaceutical preparations, including pharmaceutical preparations for... Class 005 Class 005 Pharmaceutical Products Pharmaceutical preparations, including pharmaceutical preparations for the treatment and prevention of blood disorders, cancer/oncology, cardiovascular diseases, central nervous systems diseases and disorders, dermatological disorders, diabetes, diabetic neuropathy, endocrine disorders, gastrointestinal disorders, hormonal diseases and disorders, immunological, bacterial, viral and fungal disorders, infectious diseases, inflammation and inflammatory diseases, musculoskeletal disorders, neurodegenerative disorders, neurological disorders, obesity, ophthalmologic conditions and diseases, pain, peripheral nervous system diseases and disorders, reproductive disorders, sexual dysfunction, sepsis, urological disorders | |
